IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer - Mace, T. A., Shakya, R., Pitarresi, J. R., Swanson, B., McQuinn, C. W., Loftus, S., Nordquist, E., Cruz-Monserrate, Z., Yu, L., Young, G., Zhong, X., Zimmers, T. A., Ostrowski, M. C., Ludwig, T., Bloomston, M., Bekaii-Saab, T., Lesinski, G. B. (BMJ Publishing Group, 2018)
6134903